Monthly Archives: October 2019

Servier Begins a Massive Trial over Mediator.

  Btobioinnovation.com Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation  jcm9144@gmail.com   SPECIAL REPORT #28   Servier Begins a Massive Trial over Mediator.   French pharma Laboratoires Servier begins trial today, in Paris, as the company stands accused of manslaughter and deceit over Mediator, a diabetes weight loss drug supposed to be linked to as many as […]

read more

Is this Setback the Last Nail in the Amyloid-beta Coffin?

  Btobioinnovation.com   Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation  jcm9144@gmail.com     SPECIAL REPORT #19.27   Dear Readers,   We had a very long summer break and we are now resuming our editorial activities with a special report dedicated once again to a major failure of an Alzheimer’s drug.     Is this Setback the […]

read more

Scott Gottlieb, the former FDA Commissioner, joins the Board of Pfizer

  Btobioinnovation.com   Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation  jcm9144@gmail.com   SPECIAL REPORT #26   Scott Gottlieb, the former FDA Commissioner, joins the Board of Pfizer       Just 85 days after resigning, on April 5, from its position as US FDA Commissioner, Scott Gottlieb joins the Board of Pfizer as a non-executive director. […]

read more